Zealand Pharma A/S
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG0018JWYS7
ZEAL
Zealand Pharma A/S
GICS: 35201010
·
Sector: Health Care
·
Sub-Sector: Health Care
NAME
Zealand Pharma A/S
ISIN
DK0060257814
TICKER
ZEAL
MIC
XCSE
REUTERS
ZEAL.CO
BLOOMBERG
ZEAL DC
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
In this section you will find transaction histories for short sales.
ai
NALIZER
Short sellers are obliged to report when building up positions from 0.50% and when reducing positions up to 0.50%. If there are open positions >= 0.50% in the reporting registers, these are shown in the following overview.
Six Short sale positions >= 0.50% are currently registered as reportable-relevant
| Date | Position Holder | Position | # | Action |
|---|---|---|---|---|
| 06.01.2025 | Capital Fund Management | 0,71% | 4 | |
| 20.12.2024 | D. E. Shaw & Co., L.P. | 0,52% | 1 | |
| 05.12.2024 | AQR Capital Management, LLC | 0,50% | 1 | |
| 05.12.2024 | Qube Research & Technologies Ltd | 0,80% | 15 | |
| 09.07.2024 | Arrowstreet Capital Limited Partnership | 0,61% | 16 | |
| 22.08.2023 | Perceptive Advisors LLC | 0,72% | 6 |
The overview shows all positions and their last reported status. Please note that when reducing positions, falling below the 0.50% limit means that the mandatory reporting obligations no longer have to be applied. As a rule, it can be assumed that the positions have been completely reduced following a longer period of inactivity. Positions < 0.50% are therefore only of limited significance.
| Date | Position Holder | Position | # | Action |
|---|---|---|---|---|
| 06.01.2025 | Capital Fund Management | 0,71% | 4 | |
| 20.12.2024 | D. E. Shaw & Co., L.P. | 0,52% | 1 | |
| 05.12.2024 | AQR Capital Management, LLC | 0,50% | 1 | |
| 05.12.2024 | Qube Research & Technologies Ltd | 0,80% | 15 | |
| 09.07.2024 | Arrowstreet Capital Limited Partnership | 0,61% | 16 | |
| 22.08.2023 | Perceptive Advisors LLC | 0,72% | 6 | |
| 21.04.2023 | Armistice Capital, LLC | 0,49% | 26 | |
| 05.04.2023 | Voleon Capital Management LP | 0,45% | 40 | |
| 17.02.2023 | D. E. Shaw Investment Management, L.L.C. | 0,49% | 2 | |
| 03.10.2022 | WorldQuant LLC | 0,38% | 75 | |
| 29.08.2022 | HRTEU Limited | 0,11% | 2 | |
| 25.03.2022 | Marshall Wace LLP | 0,49% | 63 | |
| 08.03.2022 | Balyasny Europe Asset Management LLP | 0,47% | 6 | |
| 30.03.2020 | Citadel Advisors LLC | 0,46% | 4 | |
| 11.01.2019 | Squarepoint Ops LLC | 0,49% | 4 | |
| 05.03.2018 | GSA Capital Partners LLP | 0,46% | 22 | |
| 19.12.2016 | Bogle Investment Management, L.P. | 0,47% | 2 |
Information on product placements
The information provided in this area is compiled with care and prepared and processed in complex technical process steps. Quality assurance is an integral part of the methods and procedures used. A plausibility check is carried out to the extent that the source data allows. Before further use, especially in the course of any investment decisions, we recommend consulting at least one second independent source for validation.
SMART * AD
P R O D U C T S U G G E S T I O N S
